Characteristics of Interstitial Fibrosis and Inflammatory Cell Infiltration in Right Ventricles of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
International Journal of Rheumatology · 2010 · 2010 · 1-10
DOI: 10.1155/2010/604615 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Rheumatology, 2010. Verfasst von Maria J Overbeek und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Diseases, VU University Medical Center, VU University Amsterdam, De Boelelaan 1117, NL 1007 MB Amsterdam, The Netherlands. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Objective
Systemic sclerosis-associated pulmonary arterial hypertension (SScPAH) has a disturbed function of the right ventricle (RV) when compared to idiopathic PAH (IPAH). Systemic sclerosis may also affect the heart. We hypothesize that RV differences may occur at the level of interstitial inflammation and—fibrosis and compared inflammatory cell infiltrate and fibrosis between the RV of SScPAH, IPAH, and healthy controls.
Methods
Paraffin-embedded tissue samples of RV and left ventricle (LV) from SScPAH ( n = 5 ) and IPAH ( n = 9 ) patients and controls ( n = 4 ) were picrosirius red stained for detection of interstitial fibrosis, which was quantified semiautomatically. Neutrophilic granulocytes (MPO), macrophages (CD68), and lymphocytes (CD45) were immunohistochemically stained and only interstitial leukocytes were counted. Presence of epi- or endocardial inflammation, and of perivascular or intimal fibrosis of coronary arteries was assessed semiquantitatively (0–3: absent to extensive).
Results
RV's of SScPAH showed significantly more inflammatory cells than of IPAH (cells/ mm 2 , mea n ± s d MPO 11 ± 3 versus 6 ± 1 ; CD68 1 1 ± 3 versus 6 ± 1 ; CD45 1 1 ± 1 versus 5 ± 1 , P < .05 ) and than of controls. RV interstitial fibrosis was similar in SScPAH and IPAH ( 4 ± 1 versus 5 ± 1 %, P = .9 ), and did not differ from controls ( 5 ± 1 %, P = .8 ). In 4 SScPAH and 5 IPAH RV's foci of replacement fibrosis were found. No differences were found on epi- or endocardial inflammation or on perivascular or intimal fibrosis of coronary arteries.
Conclusion
SScPAH RVs display denser inflammatory infiltrates than IPAH, while they do not differ with respect to interstitial fibrosis. Whether increased inflammatory status is a contributor to altered RV function in SScPAH warrants further research.
Autor:innen und Institutionen
- Department of Pulmonary Diseases, VU University Medical Center, VU University Amsterdam, De Boelelaan 1117, NL 1007 MB Amsterdam, The Netherlands.
Zitieren
APA
Overbeek, M. J., Mouchaers, K. T., Niessen, H. M., Hadi, A. M., Kupreishvili, K., Boonstra, A., Voskuyl, A. E., Belien, J. A., Smit, E. F., Dijkmans, B. C., Vonk-Noordegraaf, A., & Grünberg, K. (2010). Characteristics of Interstitial Fibrosis and Inflammatory Cell Infiltration in Right Ventricles of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension. International Journal of Rheumatology, 2010, 1-10. https://doi.org/10.1155/2010/604615
Vancouver
Overbeek MJ, Mouchaers KT, Niessen HM, Hadi AM, Kupreishvili K, Boonstra A, et al. Characteristics of Interstitial Fibrosis and Inflammatory Cell Infiltration in Right Ventricles of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension. International Journal of Rheumatology. 2010;2010:1-10. doi:10.1155/2010/604615
BibTeX
@article{Overbeek2010,
author = {Overbeek, Maria J and Mouchaers, Koen T B and Niessen, Hans M and Hadi, Awal M and Kupreishvili, Koba and Boonstra, Anco and Voskuyl, Alexandre E and Belien, Jeroen A M and Smit, Egbert F and Dijkmans, Ben C and Vonk-Noordegraaf, Anton and Grünberg, Katrien},
title = {Characteristics of Interstitial Fibrosis and Inflammatory Cell Infiltration in Right Ventricles of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension},
journal = {International Journal of Rheumatology},
year = {2010},
volume = {2010},
pages = {1--10},
doi = {10.1155/2010/604615}
}
EUVIMED